A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents?

Statins and Primary Atherosclerotic Cardiovascular Disease Prevention—What We Know, Where We Need to Go, and Why Are We Not There Already?

“…13 Clinical inertia, statin-associated adverse effects, and social media all play roles in suboptimal use of statin therapy in clinical practice. 14 System-level interventions are needed to assist clinicians in implementing evidence-based statin therapy use in primary prevention. Thoughtful conversations are also needed with patients to counter the misinformation about statin therapy that is pervasive in social media.…”

“…Study after study has shown that statin therapy use remains low in primary ASCVD prevention . Clinical inertia, statin-associated adverse effects, and social media all play roles in suboptimal use of statin therapy in clinical practice . System-level interventions are needed to assist clinicians in implementing evidence-based statin therapy use in primary prevention.…”